A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis

NCT04697056 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Administrative Reason

Conditions

Ichthyosis

Interventions

DRUG: Imsidolimab
BIOLOGICAL: placebo

Sponsor

Vanda Pharmaceuticals